Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Field
-
to unravel how plants control gene expression across different tissues and stress conditions by combining single-cell genomics, artificial intelligence, and synthetic biology. Apart from shedding light on
-
See advertisement About the position We are currently seeking applicants for a 3-year Postdoctoral Fellow position (100%) in cardiac research. The successful candidate will examine sex differences and
-
mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us
-
-fertilization of hundreds of genotypes and rearing of juvenile algae in mesocosms under different thermal scenarios. We now want to study selection dynamics in such experiments to identify genomic targets
-
conceptually different treatment strategies. Specific areas of focus are the mechanisms by which glioblastoma initiates from normal neural stem cells, how it recurs following treatment and the links between
-
including next-generation sequencing, bioinformatic analysis (R and/or python), mammalian cell culture. The post holder will be comfortable working both independently and in a collaborative environment. What
-
honor the idea that through our differences, we are better together. In working to fulfill that vision, we are comprised of more than 125 primary appointed faculty and academics, 200 staff members, and 25
-
Council of Norway and will combine high-throughput venomics, bioinformatics, evolutionary methods, and ecological modelling with the exceptional expertise in peptide chemistry and pharmacology within a
-
biology, mathematics, bioinformatics and programming. By combining cutting-edge microscopy technology with advanced computational analyses, our groups unravel novel insights into how cells function in
-
. Potential projects focus on severe ADRs to a range of different medications. Current priority ADRs include cisplatin-induced ototoxicity, anthracycline-induced cardiotoxicity, COVID-19 vaccine-induced